TRAF3 loss-of-function reveals the noncanonical NF-κB pathway as a therapeutic target in diffuse large B cell lymphoma.
Li MY, Chong LC, Duns G, Lytle A, Woolcock B, Jiang A, Telenius A, Ben-Neriah S, Nawaz W, Slack GW, et al. Proc Natl Acad Sci U S A. 2024 Apr 30; 121(18):e2320421121. Epub 2024 Apr 25.